Filing Details
- Accession Number:
- 0001562180-25-004491
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-05 16:35:02
- Reporting Period:
- 2025-06-04
- Filing Date:
- 2025-06-05
- Accepted Time:
- 2025-06-05 16:35:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2007730 | C Richard Malabre | C/O Akebia Therapeutics, Inc 245 First St. Cambridge MA 02142 | Svp, Chief Accounting Officer | No | No | No | No |
Transaction Summary
| Sold: | 13,334 shares | Avg. Price: $3.53 | Total Value: $47,069.02 |
| Number of Shares After Transactions: | 266,914 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-04 | 13,334 | $3.53 | 266,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the Reporting Person on December 12, 2024.
- The shares were sold at prices ranging from $3.50 to $3.60 and the price reported reflects the weighted average sale price.
Billionaire Hedge Funds
